CRISIL - Evalueserve news; CRISIL's rich valuation justified - Emkay

- Unconfirmed media reports suggest that promoter of Evalueserve (EVS), a KPO firm is looking to sell its stake at valuation of 12-15x CY11 EV/ EBIDTA or $250mn

- CRISIL trades at a higher EV/ EBIDTA of 26x CY11 which is justified, given its presence in more value added analytics, 25% higher rev/ employee, higher margins and RoCE

- CRISIL runs much profitable model with EBIDTA per employee in research business higher at USD16,500 vs. USD7,000 for EVS

- At CMP, CRISIL trades at 26x CY13 EPS with RoE/ RoIC in excess of 50%/ 100% respectively. Maintain ACCUMULATE with price target of Rs1,050.

Source : Equity Bulls

Keywords